Gene Query: DUSP7

Dataset Description Geneva Score
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 129.61
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 84.27
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 84.27
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 66.08
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 62.13
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 57.33
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 53.89
Irf9 function in immunity in mouse 53.89
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 44.85
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 42.03
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 40.79
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 37.94
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 37.94
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 37.32
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 34.07
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 34.07
G-quadruplex structures mark human regulatory chromatin 31.88
IL-33 activates tumor stroma to promote intestinal polyposis 31.74
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 31.29
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 30.91
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 30.91
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 30.02
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 27.36
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 23.05
Transcriptome profiling of Normal and Cancerous Prostate Cells 22.62
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 22.45
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 22.01
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 21.35
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 21.35
The regulartory role of ZCCHC24 in splicing machinery 20.94
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 20.89
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 20.89
The interplay between SOX4 and SMAD3 in the context of breast cancer 20.75
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 20.54
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 20.29
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 19.75
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 19.69
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 19.67
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 19.45
CD95/Fas ligand mRNA is toxic to cells 19.21
A prostate cancer chromatin interaction map 19.06
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 18.72
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 18.36
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 17.99
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 17.91
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 17.91
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 17.82
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 17.31
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 17.31
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 16.82
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 16.82
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 16.32
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 16.06
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 15.96
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 15.96
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 15.86
Transcriptomic and gene ontology profiling of the human corneal cell types 15.8
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 15.46
RNA expression following TMPRSS11B overexpression or depletion 15.03
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 14.61
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 14.56
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 14.4
Gene expression changes caused by KRAS in MCF-10A 14.37
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 14.22
Fbxo32 mediated gene expression program underlies EMT and metastasis 13.96
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 13.84
Ro60-knockout cells 13.73
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 13.65
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 13.65
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 13.42
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 13.4
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 13.4
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 13.35
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 13.32
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 13.24
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 12.79
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 12.78
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 12.71
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 12.63
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 12.6
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 12.6
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 12.53
CSL RNA-Seq on HKC and SCC cell lines 12.52
CSL 12.52
Selective expression of long non-coding RNAs in a breast cancer cell progression model 12.44
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 12.38
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 12.26
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 12.15
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 12.15
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 12.07
Paxillin regulates genomic networks in prostate cancer [PC3] 12.06
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 11.83
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 11.82
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 11.71
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 11.64
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 11.54
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 11.43
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 11.36
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 11.2
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 11.03
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 11.03
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 10.79
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 10.72
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 10.6
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 10.57
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 10.39
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 10.14
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 10.13
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 9.97
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 9.88
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 9.84
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 9.84
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 9.77
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 9.73
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 9.73
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 9.64
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 9.53
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 9.5
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 9.5
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 9.42
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 9.42
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 9.42
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 9.36
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 9.28
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 9.21
Differential gene expression of human melanoma cells [RNA-seq] 9.21
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 9.19
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 9.18
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 9.14
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 8.95
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 8.82
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 8.81
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 8.78
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 8.78
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 8.78
RNAseq of HEK293 cells after Chtop knockdown 8.76
Co-transcriptional loading of RNA export factors shapes the human transcriptome 8.76
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 8.64
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 8.64
Gene expression changes associated with resistance to tagraxofusp (SL-401) 8.64
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 8.61
Generation of KRAS signatures using immortalized isogenic lung cells. 8.54
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 8.5
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 8.49
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 8.44
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 8.42
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 8.42
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 8.41
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 8.41
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 8.41
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 8.4
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 8.37
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 8.37
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 8.33
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 8.33
Epigenome regulation during epidermal lineage commitment [RNA-seq] 8.33
Inhibition of TNBC metastasis by Gpx1 8.31
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 8.26
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 8.24
RNA-seq analysis of AML cells in response to ASLAN003 7.96
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 7.96
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 7.95
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 7.93
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 7.91
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 7.91
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 7.89
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 7.71
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 7.71
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 7.7
Targeted enhancer activation by a subunit of the integrator complex 7.68
MYCi361 regulates MYC target genes 7.67
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 7.65
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 7.62
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 7.61
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 7.59
Transcriptomic analyssis following EHMT1/2 inhibition 7.58
Entrectinib Resistance in a Neuroblastoma Xenograft Model 7.53
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 7.52
MCF10A H-Ras RNA-Seq 7.52
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 7.48
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 7.47
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 7.45
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 7.45
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 7.33
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 7.33
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 7.29
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 7.19
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 7.14
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 7.12
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 7.1
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 7.1
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 7.07
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 7.04
Role of COP1 on MAP kinase transcriptional output in melanoma 7.04
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 6.99
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 6.83
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 6.81
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 6.79
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 6.79
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 6.74
snRNAs as regulators of alternative splicing 6.72
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 6.7
Transcriptional profile in human S. haematobium infection 6.67
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 6.65
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 6.65
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 6.63
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 6.6
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 6.56
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 6.51
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 6.51
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 6.5
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 6.47
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 6.46
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 6.41
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 6.4
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 6.37
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 6.37
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 6.35
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 6.31
Global gene expression profile of dasatinib-resistant RCH-ACV cells 6.26
Targeting MTHFD2 in Acute Myeloid Leukemia 6.19
BAF controls genome accessibility 6.17
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 6.16
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 6.15
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 6.1
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 6.08
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 6.08
A transcriptome-wide divergence in protein translation scales with LIN28B expression 6.08
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 6.07
Generation of trichogenic adipose-derived stem cells by expression of three factors 6.02
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 6.0
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 6.0
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 6.0
Epigenome regulation during epidermal lineage commitment 5.97
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 5.97
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 5.95
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 5.93
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 5.92
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 5.89
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 5.88
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 5.86
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 5.84
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 5.83
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 5.81
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 5.81
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 5.78
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 5.78
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 5.77
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 5.74
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 5.71
4sU-seq of HFF exposed to salt and heat stress 5.7
AUF-1 affected genes in human skin cells 5.69
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 5.68
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 5.68
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 5.68
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 5.66
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 5.63
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 5.63
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 5.61
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 5.54
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 5.53
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 5.51
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 5.51
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 5.49
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 5.48
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 5.47
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 5.45
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 5.41
MARCKS and lnc-MARCKS act as inflammation regulators 5.39
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 5.33
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 5.33
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 5.33
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 5.33
Identification of differentially expressed genes between senescence and senescence bypass cells 5.32
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 5.31
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 5.31
RNA-seq analysis of BAP1-depleted uveal melanoma cells 5.31
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 5.31
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 5.28
Effect of ILF3 on translation during homeostasis and the antiviral response 5.25
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 5.24
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 5.22
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 5.2
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 5.18
Transcriptome analysis of SKI knock-out in HL60 cells 5.18
Transcriptomic analysis of ERR alpha orphan nuclear receptor 5.18
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 5.18
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 5.17
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 5.17
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 5.16
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 5.13
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 5.11
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 5.1
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 5.1
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 5.09
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 5.08
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 5.05
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 5.04
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 4.99
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 4.99
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 4.98
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 4.96
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 4.96
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 4.86
Macrophage Ad5f35 M2 Challenge 4.86
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 4.84
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 4.77
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 4.77
MicroRNA-125a-5p overexpression in human macrophages 4.76
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 4.75
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 4.75
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 4.75
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 4.73
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 4.72
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 4.68
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 4.65
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 4.62
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 4.61
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 4.59
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 4.58
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 4.58
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 4.48
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 4.47
mRNA expression profile of Lymphocytes 4.44
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 4.43
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 4.41
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 4.37
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 4.33
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 4.32
Co-regulation of splicing by Rbfox1 and hnRNP M 4.32
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 4.18
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 4.14
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 4.14
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 4.13
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 4.12
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 4.11
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 4.07
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 4.06
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 3.99
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 3.98
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 3.94
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 3.91
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 3.91
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 3.85
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 3.84
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 3.76
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 3.75
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 3.75
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 3.75
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 3.74
Downregulation of LATS kinases alters p53 to promote cell migration 3.69
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 3.66
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 3.66
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 3.64
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 3.64
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  3.57
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 3.49
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 3.49
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 3.49
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 3.47
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 3.44
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 3.44
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 3.38
RNA-sequencing in immortalized human mammary epithelial cells 3.38
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 3.35
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 3.26
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 3.23
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 3.22
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 3.22
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 3.21
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 3.18
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 3.16
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 3.1
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 3.1
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 3.1
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 3.09
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 3.09
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 3.08
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 3.08
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 3.08
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 3.06
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 3.04
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 3.01
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 2.99
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 2.98
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 2.87
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 2.86
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 2.85
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 2.85
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 2.81
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 2.74
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 2.74
Macrophage Ad5f35 PhenoMap 2.73
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 2.72
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 2.71
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 2.66
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 2.66
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 2.66
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 2.62
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 2.6
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 2.58
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 2.57
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 2.52
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 2.52
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 2.51
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 2.5
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 2.49
Expression profiling of converted and control dermal BJ fibroblasts 2.49
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 2.48
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 2.45
The pioneer factor CEBPA modulates vitamin D signaling 2.45
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 2.4
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 2.37
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 2.36
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 2.33
Zika virus infection reprograms global transcription of host cells to allow sustained infection 2.31
Dysregulated immune system networks in war veterans with PTSD 2.31
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 2.29
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 2.25
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 2.21
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 2.2
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 2.2
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 2.17
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 2.17
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 2.12
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 2.08
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 2.01
Transcriptome analysis of human lung epithelial cells 2.0
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 2.0
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 1.93
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 1.91
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 1.9
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 1.88
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 1.88
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 1.88
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 1.87
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 1.87
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 1.86
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 1.85
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 1.82
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 1.82
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 1.81
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 1.68
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 1.68
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 1.6
Identification of Sin3B regulated genes during quiescence 1.44
Metabolism as an early predictor of DPSCs aging 1.42
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 1.41
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 1.37
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 1.37
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 1.36
quanTIseq: quantifying immune contexture of human tumors 1.34
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 1.34
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 1.34
Transcriptomic analysis of LSD1 1.33
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 1.32
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 1.29
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 1.25
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 1.22
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 1.22
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 1.21
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 1.2
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 1.19
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 1.14
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 1.14
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 1.13
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 1.04
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 0.97
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 0.95
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.88
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 0.85
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 0.85
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 0.85
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.8
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 0.77
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 0.75
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 0.67
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 0.47
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.43
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 0.39
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.37
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.37
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 0.33
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 0.28
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 0.26
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.26
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 0.24
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.21
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 0.21
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.21
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 0.21
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 0.2
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 0.19
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 0.19
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.15
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.12
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.11
Glucose inhibits cardiac maturation through nucleotide biosynthesis 0.1
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 0.08
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 0.04


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation